GSK329
Modify Date: 2025-08-26 10:17:37
GSK329 structure
|
Common Name | GSK329 | ||
|---|---|---|---|---|
| CAS Number | 1268490-12-5 | Molecular Weight | 472.25 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H14Cl2F3N5O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of GSK329GSK329 is a potent and selective diarylurea inhibitor of the cardiac-specific kinase TNNI3K. GSK329 exhibits positive cardioprotective outcomes in the model of ischemia/reperfusion cardiac injury[1]. |
| Name | GSK329 |
|---|
| Description | GSK329 is a potent and selective diarylurea inhibitor of the cardiac-specific kinase TNNI3K. GSK329 exhibits positive cardioprotective outcomes in the model of ischemia/reperfusion cardiac injury[1]. |
|---|---|
| Related Catalog | |
| Target |
TNNI3K[1] |
| References |
| Molecular Formula | C19H14Cl2F3N5O2 |
|---|---|
| Molecular Weight | 472.25 |